Last reviewed · How we verify

DS-3201b

Daiichi Sankyo · Phase 1 active Small molecule Quality 20/100

At a glance

Generic nameDS-3201b
SponsorDaiichi Sankyo
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: